Literature DB >> 24698554

The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey.

A Kesler1,2, N Stolovic1, Y Bluednikov3, T Shohat3,4.   

Abstract

BACKGROUND AND
PURPOSE: Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, is a disorder related to increased intracranial pressure without clinical, laboratory or radiological evidence of an intracranial space occupying lesion or cerebral sinus vein thrombosis, predominantly affecting obese women of childbearing age. Our aim was to determine the incidence and clinical features of IIH in Israel.
METHODS: In a cross-sectional study, all medical records of patients discharged from the hospital with a primary diagnosis of IIH during 2005-2007 were reviewed.
RESULTS: Four hundred and twenty-eight patients with a new onset of IIH were diagnosed. The average annual incidence rate was 2.02 per 100,000 with an incidence of 3.17 per 100,000 for women and 0.85 per 100,000 for men. The incidence rate in females of childbearing age (18-45) was 5.49 per 100,000. The female to male ratio for >17 years old was 6.1:1 (252 females and 41 males) and 2.1:1 (60 females and 28 males) for ages 11-17. Obesity was documented in 83.4% of patients. Body mass index (BMI) data were available for 159 (37.1%) patients; of these, 59.1% had a BMI ≥ 30.
CONCLUSION: The incidence of IIH in Israel has increased during the last decade. This finding could be related to the increasing rates of obesity. The association of IIH and obesity should be further explored especially with regard to the effect of weight reduction for primary prevention.
© 2014 The Author(s) European Journal of Neurology © 2014 EAN.

Entities:  

Keywords:  Israel; idiopathic intracranial hypertension; incidence

Mesh:

Year:  2014        PMID: 24698554     DOI: 10.1111/ene.12442

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  14 in total

Review 1.  Idiopathic intracranial hypertension in the Middle East: A growing concern.

Authors:  Sumayya J Almarzouqi; Michael L Morgan; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2014-09-28

Review 2.  Update on Idiopathic Intracranial Hypertension.

Authors:  Sivashakthi Kanagalingam; Prem S Subramanian
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.598

Review 3.  An Up to Date Review of Pseudotumor Cerebri Syndrome.

Authors:  John Glenn Burkett; Jessica Ailani
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-02       Impact factor: 5.081

4.  Should Magnetic Resonance Venography be Performed Routinely in all Patients Undergoing Evaluation for Idiopathic Intracranial Hypertension?

Authors:  Marc Dinkin; Heather E Moss
Journal:  J Neuroophthalmol       Date:  2015-12       Impact factor: 3.042

Review 5.  Perspectives on diagnosis and management of adult idiopathic intracranial hypertension.

Authors:  Irini Chatziralli; Panagiotis Theodossiadis; George Theodossiadis; Ioannis Asproudis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-04       Impact factor: 3.117

6.  Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension.

Authors:  Raed Behbehani; Abdullah Ali; Ashraf Al-Moosa
Journal:  Neuroophthalmology       Date:  2021-10-13

Review 7.  Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases.

Authors:  Keira A Markey; Maria Uldall; Hannah Botfield; Liam D Cato; Mohammed A L Miah; Ghaniah Hassan-Smith; Rigmor H Jensen; Ana M Gonzalez; Alexandra J Sinclair
Journal:  J Pain Res       Date:  2016-04-19       Impact factor: 3.133

8.  Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.

Authors:  Keira Annie Markey; Ryan Ottridge; James L Mitchell; Caroline Rick; Rebecca Woolley; Natalie Ives; Peter Nightingale; Alexandra J Sinclair
Journal:  JMIR Res Protoc       Date:  2017-09-18

9.  Incidence of idiopathic intracranial hypertension in Southern Tasmania, Australia.

Authors:  Natasha Krishnadas; Bruce Taylor
Journal:  BMJ Neurol Open       Date:  2021-06-24

10.  The expanding burden of idiopathic intracranial hypertension.

Authors:  Susan P Mollan; Magda Aguiar; Felicity Evison; Emma Frew; Alexandra J Sinclair
Journal:  Eye (Lond)       Date:  2018-10-24       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.